Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 5/20 | 0.98 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.65 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | CHRM1 | P11229 | 8/20 | 0.57 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.57 |
| ▸ | CHRM3 | P20309 | 7/20 | 0.57 |
| ▸ | CHRM4 | P08173 | 6/20 | 0.57 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.57 |
| ▸ | BLM | P54132 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Eucatropine SCHEMBL636552 | 0.99 | LMNA (1.00) | CYP2D6LMNANR1I2ABCB11CYP2C9 | |
| Eucatropine SCHEMBL28210942 | 0.95 | CYP2D6 (0.91) | CYP2D6LMNANR1I2ABCB11CYP2C9 | |
| Cyclandelate SCHEMBL8060819 | 0.79 | LMNA (1.00) | CYP2D6LMNANR1I2ABCB11CYP2C9 | |
| Cyclandelate SCHEMBL5123 | 0.79 | LMNA (1.00) | CYP2D6LMNANR1I2ABCB11CYP2C9 | |
| Cyclandelate SCHEMBL547043 | 0.79 | LMNA (1.00) | CYP2D6LMNANR1I2ABCB11CYP2C9 | |
| Homatropine SCHEMBL23468168 | 0.74 | LMNA (1.00) | CYP2D6LMNANR1I2ABCB11CYP2C9 | |
| Homatropine SCHEMBL9653008 | 0.74 | LMNA (1.00) | CYP2D6LMNANR1I2ABCB11CYP2C9 | |
| Homatropine SCHEMBL15275620 | 0.74 | LMNA (1.00) | CYP2D6LMNANR1I2ABCB11CYP2C9 | |
| Homatropine SCHEMBL23970 | 0.74 | LMNA (1.00) | CYP2D6LMNANR1I2ABCB11CYP2C9 | |
| Homatropine SCHEMBL23969 | 0.74 | LMNA (1.00) | CYP2D6LMNANR1I2ABCB11CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2123 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724079-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Stealth BioTherapeutics Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| US-20260048096-A1 | METHODS AND COMPOSITIONS FOR PRESERVING THE RETINAL OUTER NUCLEAR LAYER (ONL), PHOTORECEPTORS, AND RETINAL THICKNESS | STEALTH BIOTHERAPEUTICS INC. (US) | 2026-02-19 | — | — | US | claimed |
| EP-4596049-A2 | PEPTIDE FOR USE IN PREVENTING OR TREATING MACULAR DEGENERATION | Stealth BioTherapeutics Inc. (US) | 2025-08-06 | — | — | EP | claimed |
| EP-4302829-B1 | PEPTIDE FOR USE IN PREVENTING OR TREATING MACULAR DEGENERATION | STEALTH BIOTHERAPEUTICS INC (US) | 2025-05-21 | — | — | EP | claimed |
| US-20250090621-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | STEALTH BIOTHERAPEUTICS INC. (US) | 2025-03-20 | — | — | US | claimed |
| WO-2024254164-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | STEALTH BIOTHERAPEUTICS INC. (US) | 2024-12-12 | — | — | WO | claimed |
| US-20240350577-A1 | METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING DOMINANT OPTIC ATROPHY | STEALTH BIOTHERAPEUTICS INC. (US) | 2024-10-24 | — | — | US | claimed |
| EP-3413872-B1 | NON-INVASIVE OCULAR DRUG DELIVERY INSERT TECHNOLOGY | UNIV DE COIMBRA (PT) | 2024-10-02 | — | — | EP | claimed |
| EP-4419123-A1 | METHODS AND COMPOSITIONS COMPRISING PEPTIDOMIMITICS FOR TREATING, PREVENTING, INHIBITING, AMELIORATING OR DELAYING THE ONSET OF OPHTHALMIC CONDITIONS | Stealth BioTherapeutics Inc. (US) | 2024-08-28 | — | — | EP | claimed |
| WO-2024163315-A2 | DERIVATIZED COLLAGEN-HYALURONIC ACID BASED IMPLANTS FOR SUSTAINED DELIVERY OF OPHTHALMIC DRUGS | DEVORE DALE (US) | 2024-08-08 | — | — | WO | claimed |
| EP-0126684-B1 | DRUG DELIVERY SYSTEM UTILIZING THERMOSETTING GELS | MERCK & CO. INC. (US) | 1991-08-28 | — | — | EP | claimed |
| US-4720494-A | Anticholinergic eucatropine esters and antiperspirant use thereof | THE GILLETTE COMPANY (US) | 1988-01-19 | — | — | US | claimed |
| US-4546096-A | Anticholinergic glucuronides and antiperspirant use thereof | REPLIGEN CORPORATION (US) | 1985-10-08 | — | — | US | claimed |
| EP-0154446-A2 | Anti-cholinergic glucuronides and their anti-perspirant use | REPLIGEN CORPORATION (US) | 1985-09-11 | — | — | EP | claimed |
| EP-0126684-A2 | Drug delivery system utilizing thermosetting gels | MERCK & CO. INC. (US) | 1984-11-28 | — | — | EP | claimed |
| US-4474751-A | SUSTAINED RELEASE USING AN ALKYLENEDIAMINE-MODIFIED ETHYLENE OXIDE-PROPYLENE OXIDE COPOLYMER | MERCK & CO., INC. (US) | 1984-10-02 | — | — | US | claimed |
| US-4186184-A | Selective administration of drug with ocular therapeutic system | ALZA CORPORATION (US) | 1980-01-29 | — | — | US | claimed |
| US-4186185-A | Compositions comprising arylene substituted poly(orthoesters) containing useful agents | ALZA CORPORATION (US) | 1980-01-29 | — | — | US | claimed |
| US-4066747-A | Polymeric orthoesters housing beneficial drug for controlled release therefrom | ALZA CORPORATION (US) | 1978-01-03 | — | — | US | claimed |
| US-4014335-A | Ocular drug delivery device | ALZA CORPORATION (US) | 1977-03-29 | — | — | US | claimed |